•  12/1/2020 07:11 AM

According to sources at the Ministry of Foreign Affairs and the Indian High Commission in Dhaka, the chances of the virtual meeting between the two prime ministers taking place on December 17 are as much as 90%.

Read More
  •  11/30/2020 08:52 AM

The government is paying about $30 million, or Tk 260 crore, more than the price set by AstraZeneca to buy three crore doses of the Oxford COVID-19 vaccine from its manufacturer Serum Institute of India through its local vendor Beximco Pharmaceuticals.

Read More
  •  11/30/2020 08:24 AM

The Serum Institute of India issued a statement on Sunday regarding a participant in its Covid vaccine trial falling seriously ill during the trial stating that "there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer".

Read More
  •  11/27/2020 10:25 AM

MOSCOW: Indian pharmaceutical company Hetero will manufacture over 100 million doses of the Russian Sputnik V COVID-19 vaccine per year under the terms of a deal unveiled on Friday between it and Russia’s RDIF sovereign wealth fund.

Read More
  •  11/27/2020 09:19 AM

For so many, 2020 has been a bleak year filled with uncertainty and anxiety directly related to the COVID-19 pandemic that has surged across the globe and led to the deaths of more than 1.4 million people, including close to 260,000 in the United States.

Read More
  •  11/24/2020 01:35 AM

The British drug maker said on Monday that the vaccine could be around 90% effective, when administered as a half dose followed by a full dose a month later, citing data from late-stage trials in Britain and Brazil.

Read More
  •  11/18/2020 02:03 AM

Pfizer-Biontech and Moderna recently announced the first interim efficacy analysis of their Covid-19 vaccines. The financial markets cheered the news as an early marker of success. Divya Rajagopal explains what the trial landmark means

Read More
  •  11/18/2020 01:17 AM

Inovio Pharmaceuticals has received US FDA’s approval to commence a mid-stage study of its COVID-19 vaccine candidate. The trial for the vaccine, INO-4800, will be funded by the US Department of Defense, the company said.

Read More
  •  11/17/2020 12:18 AM

Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial, another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control a worsening pandemic

Read More
  •  11/17/2020 12:06 AM

Only a week after Pfizer and BioNTech’s preliminary data readout of its COVID-19 vaccine suggested a 90% efficacy rate, Moderna reported interim efficacy data for its vaccine of 94.5%. This is particularly excellent news given the surge of the disease and the distribution difficulties surrounding the Pfizer-BioNTech effort.

Read More
  •  11/16/2020 04:34 AM

The European Commission has secured a supply deal with BioNTech and Pfizer for 300 million doses of their COVID-19 vaccine candidate. This includes an initial order for 200 million doses for all EU Member States, as well as an additional option to purchase another 100 million doses of the vaccine if it is proven to be safe and effective against COVID-19.

Read More
  •  11/16/2020 01:54 AM

Eli Lilly’s antibody neutralizing antibody bamlanivimab (LY-CoV555) is the latest bright spot in the battle against COVID-19. Despite the greenlight from the U.S. Food and Drug Administration (FDA) as an emergency treatment, there are some questions about how effective the treatment will actually prove to be due to labeling limitations.

Read More